NCT00038831 Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS Status COMPLETED Phase PHASE1/PHASE2
NCT00034528 Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia Status TERMINATED Phase PHASE2
NCT00010361 Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders Status COMPLETED Phase NA
NCT00005898 Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia Status COMPLETED Phase PHASE1/PHASE2
NCT00004485 Bone Marrow Transplantation in Treating Children With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT00003552 Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma Status TERMINATED Phase PHASE1/PHASE2
NCT00001832 Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00001677 Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy Status COMPLETED Phase PHASE2
NCT00001422 A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis Status COMPLETED Phase PHASE2